NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM219864 Query DataSets for GSM219864
Status Public on Feb 19, 2008
Title Azaspiracid (1nM)_Jurkat_24 hr_array #105_+
Sample type RNA
 
Channel 1
Source name Jurkat cells exposed to MeOH (o.1% v/v)
Organism Homo sapiens
Characteristics Human Jurkat E6-1 lymphocyte T cells (ATCC# TIB-152)
Biomaterial provider ATCC (American Type Culture Collection)
Treatment protocol For each experimental replicate (n = 3), 60 ml of cell culture were centrifuged at 1000 x g for 7 min and resuspended in 40 ml of fresh RPMI medium supplemented with FBS. Freshly resuspended cells were inoculated into 35 mm Petri dishes containing 2 ml total volume. Total cell numbers per dish ranged between 4.4 and 10.6 x 106 cells for the biological replicates at each time point. Cells were grown for >12 hr prior to addition of AZA-1 (1 nM final) or equivalent amounts of methanolic vehicle (0.1% final) in order to allow recovery from any stress induced by centrifugation. The cells were harvested for RNA extractions at 24 hr.
Growth protocol Human Jurkat E6-1 lymphocyte T cells (American Type Culture Collection #TIB-152; Manassas, VA, USA) were grown in RPMI medium supplemented with 10% (v/v) fetal bovine serum (FBS) and maintained in humidified 5%:95% CO2:air at 37 oC. Cells were subcultured every 5 to 7 days with fresh medium by transferring 1 ml of cells to 9 ml of fresh supplemented medium in 75 cm^2 screw cap culture flasks.
Extracted molecule total RNA
Extraction protocol Immediately following centrifugation at 1000 x g for 5 min, cells were disrupted by resuspending in 1 ml Tri-Reagent (Molecular Research Center, Inc., Cincinnati, OH, USA). All samples were processed according to manufacturer?s protocol. Total RNA was resuspended in DEPC water, purified with a Qiagen RNeasy column (Valencia, CA, USA), and quantified by UV-vis spectroscopy. The RNA was then qualified on an Agilent 2100 Bioanalyzer (Palo Alto, CA, USA) to confirm the yield of high quality RNA.
Label CY3
Label protocol Four hundred nanograms of total RNA from each time-matched control and treatment sample were amplified separately and labeled with either Cy3 or Cy5 conjugated CTP (Perkin Elmer, Boston, MA, USA) with a low input linear amplification kit (Agilent Technologies, Palo Alto, CA, USA) according to manufacturer’s protocol. After labeling and clean up, amplified RNA was quantified by UV-vis spectroscopy. One microgram each of Cy3- and Cy5-labeled targets were combined and hybridized to an Agilent whole human genome oligonucleotide microarray (cat.# G4112A) array for 17 hr at 60°C. After hybridization, arrays were washed consecutively in solutions of 6X SSPE with 0.005% N-lauroylsarcosine and 0.06X SSPE with 0.005% N-lauroylsarcosine for 1 minute each at room temperature, followed by a 30 s rinse in Agilent stabilization and drying solution. Biological replicates, including a dye swap, were performed at each time point.
 
Channel 2
Source name Jurkat cells exposed to azaspiracid (1 nM)
Organism Homo sapiens
Characteristics Human Jurkat E6-1 lymphocyte T cells (ATCC# TIB-152)
Biomaterial provider ATCC (American Type Culture Collection)
Treatment protocol For each experimental replicate (n = 3), 60 ml of cell culture were centrifuged at 1000 x g for 7 min and resuspended in 40 ml of fresh RPMI medium supplemented with FBS. Freshly resuspended cells were inoculated into 35 mm Petri dishes containing 2 ml total volume. Total cell numbers per dish ranged between 4.4 and 10.6 x 106 cells for the biological replicates at each time point. Cells were grown for >12 hr prior to addition of AZA-1 (10 nM final; 3-fold the 24 hr EC50; Twiner et al. (2005)) or equivalent amounts of methanolic vehicle (0.1% final) in order to allow recovery from any stress induced by centrifugation. The cells were harvested for RNA extractions at 1, 4, and 24 hr.
Growth protocol Human Jurkat E6-1 lymphocyte T cells (American Type Culture Collection #TIB-152; Manassas, VA, USA) were grown in RPMI medium supplemented with 10% (v/v) fetal bovine serum (FBS) and maintained in humidified 5%:95% CO2:air at 37 oC. Cells were subcultured every 5 to 7 days with fresh medium by transferring 1 ml of cells to 9 ml of fresh supplemented medium in 75 cm^2 screw cap culture flasks.
Extracted molecule total RNA
Extraction protocol Immediately following centrifugation at 1000 x g for 5 min, cells were disrupted by resuspending in 1 ml Tri-Reagent (Molecular Research Center, Inc., Cincinnati, OH, USA). All samples were processed according to manufacturer?s protocol. Total RNA was resuspended in DEPC water, purified with a Qiagen RNeasy column (Valencia, CA, USA), and quantified by UV-vis spectroscopy. The RNA was then qualified on an Agilent 2100 Bioanalyzer (Palo Alto, CA, USA) to confirm the yield of high quality RNA.
Label cy5
Label protocol Four hundred nanograms of total RNA from each time-matched control and treatment sample were amplified separately and labeled with either Cy3 or Cy5 conjugated CTP (Perkin Elmer, Boston, MA, USA) with a low input linear amplification kit (Agilent Technologies, Palo Alto, CA, USA) according to manufacturer’s protocol. After labeling and clean up, amplified RNA was quantified by UV-vis spectroscopy. One microgram each of Cy3- and Cy5-labeled targets were combined and hybridized to an Agilent whole human genome oligonucleotide microarray (cat.# G4112A) array for 17 hr at 60°C. After hybridization, arrays were washed consecutively in solutions of 6X SSPE with 0.005% N-lauroylsarcosine and 0.06X SSPE with 0.005% N-lauroylsarcosine for 1 minute each at room temperature, followed by a 30 s rinse in Agilent stabilization and drying solution. Biological replicates, including a dye swap, were performed at each time point.
 
 
Hybridization protocol Microarrays were imaged using an Agilent microarray scanner. Images were extracted with Agilent Feature Extraction software version A7.5.1 and data analyzed with the Rosetta Resolver 7.0 gene expression analysis system (Rosetta Informatics, Seattle, WA, USA). Using a rank consistency filter, features were subjected to a combination linear and LOWESS normalization algorithm (www.agilent.com). Based on the Rosetta error model designed for the Agilent platform, a composite array was generated at each time point, in which the data for each feature underwent a weighted averaging based on feature quality in the triplicate arrays making up the composite.
Scan protocol Arrays were scanned with an Agilent microarray scanner at a 10 um scan resolution. Scans were with both the red and green PMT concurrently. Adjustments were made to the PMT intensity as necessary.
Description 24 hr exposure; 1 nM AZA-1
Data processing Agilent Feature Extraction 7.5.1
 
Submission date Aug 22, 2007
Last update date Dec 17, 2007
Contact name Mike Twiner
E-mail(s) Mike.Twiner@noaa.gov
Phone 1-843-762-8649
Organization name NOAA/NOS
Department Marine Biotoxins
Street address 219 Fort Johnson Rd
City Charleston
State/province SC
ZIP/Postal code 29412
Country USA
 
Platform ID GPL1708
Series (1)
GSE8845 Azaspiracid exposure to lymphocyte T cells

Data table header descriptions
ID_REF
Log(Error) Log 10 error
Log(Ratio) Log 10 ratio (AZA / MeOH)
VALUE log2 of PRE_VALUE
Fold Change AZA / MeOH
P-value significance p value
Log(Intensity) log 10
Intensity1 cy3 intensity (MeOH control)
Intensity2 cy5 intensity (AZA treatment)
PRE_VALUE Ratio (AZA / MeOH)

Data table
ID_REF Log(Error) Log(Ratio) VALUE Fold Change P-value Log(Intensity) Intensity1 Intensity2 PRE_VALUE
1 2.02213 1.00419 3.3358 10.09689 0.61947 1.65297 14.15379 142.9093 10.09689
2 1.79252 1.12123 3.7246 13.21998 0.53164 1.68304 13.25648 175.2504 13.21998
3 1.65822 1.11933 3.7183 13.16238 0.49966 1.71658 14.35199 188.9063 13.16238
4 0.22216 0.30934 1.0276 2.03866 0.16378 2.76077 403.73361 823.07593 2.03866
5 3.37862 -0.46433 -1.5425 -2.91292 0.89069 1.50572 54.68649 18.77376 0.3433
6 2.10864 0.99027 3.2896 9.77835 0.63862 1.63756 13.88113 135.7345 9.77835
7 0.13694 0.17357 0.5766 1.49132 0.205 3.04682 912.07849 1360.19702 1.49132
8 0.10573 0.10892 0.3618 1.28506 0.30291 3.19178 1371.88098 1762.94897 1.28506
9 0.28224 0.10772 0.3578 1.28151 0.70271 2.63491 381.10901 488.39551 1.28151
10 1.50012 1.20128 3.9906 15.8956 0.42326 1.74339 13.89149 220.81351 15.8956
11 0.1032 0.24943 0.8286 1.77593 0.01565 3.20852 1212.84302 2153.92896 1.77593
12 0.29167 0.76551 2.5430 5.82782 0.00868 2.56505 152.1573 886.74487 5.82782
13 0.36771 0.27421 0.9109 1.88022 0.45584 2.49374 227.3213 427.4133 1.88022
14 0.10792 0.26638 0.8849 1.84663 0.01357 3.18204 1119.05396 2066.4729 1.84663
15 7.09037 0 0.0000 1 1 1.21246 15.02312 17.70731 1
16 0.65481 0.41474 1.3777 2.59862 0.52649 2.21447 101.6473 264.1423 2.59862
17 0.41953 0.55991 1.8600 3.63 0.18201 2.40722 134.0489 486.5968 3.63
18 0.20654 0.15027 0.4992 1.4134 0.4669 2.80982 542.86072 767.28027 1.4134
19 0.4707 0.01893 0.0629 1.04454 0.96793 2.38242 236.0222 246.53529 1.04454
20 1.30324 0.14271 0.4741 1.38902 0.9128 1.92864 71.99272 99.99941 1.38902

Total number of rows: 41058

Table truncated, full table size 3243 Kbytes.




Supplementary data files not provided
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap